Further establishes company’s leadership and commitment to regulatory and health issues
SCOTTSDALE, Ariz. - Friday, November 22nd 2013 [ME NewsWire]
(BUSINESS WIRE)-- NJOY, America’s number one independent electronic cigarette company, today announced the addition of two members to the Company’s senior leadership team, adding Dr. Joshua Rabinowitz as Chief Scientist and David Graham as Senior Vice President for International Regulatory Affairs. The addition of these highly-respected and experienced executives to oversee the company’s scientific research and international regulatory affairs reflects the commitment of NJOY to leadership in obsoleting tobacco cigarette smoking worldwide.
Dr. Joshua Rabinowitz, currently serving as a consultant, will join NJOY full time effective February 1, 2014. Dr. Rabinowitz is responsible for all science-related aspects of the business, including the laboratory and clinical testing of NJOY products, and oversight of product manufacturing and quality control. He will work closely with former U.S. Surgeon General Dr. Richard Carmona, the head of NJOY’s Scientific Advisory Committee.
Dr. Rabinowitz comes to NJOY on a leave of absence from Princeton University, where he is a full professor in the Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics. Dr. Rabinowitz received both an M.D. and Ph.D. from Stanford University. Thereafter, he co-founded Alexza Pharmaceuticals, where he invented the Adasuve Inhaler for treatment of acute agitation, an FDA-approved inhalation drug product. Dr. Rabinowitz is an inventor of more than 130 U.S. Patents and author of over 110 major journal articles, including seven in the past four years in Science or Nature.
David Graham, in a newly created position, will oversee all regulatory affairs in the U.S. and abroad. Mr. Graham was previously Senior Director of International Government Affairs at Johnson & Johnson, where he led tobacco control-related public policy for key markets around the globe. Before joining Johnson & Johnson, he was Senior Director of Global Public Policy for Pfizer, where he led public policy for their Tobacco Dependence business. Mr. Graham is a graduate of Columbia University School of International & Public Affairs with a Masters in Public Policy & Administration. He has more than 20 years of experience with tobacco control, smoking cessation, and related regulatory reforms.
“NJOY is committed to the scientific understanding of our products and advancing research of the e-cigarette industry. Recruiting individuals of this caliber is a testament to our early success, our Gold Standard practices and above all our full commitment to our mission—to obsolete cigarettes,” said Craig Weiss, Chief Executive Officer of NJOY. “Dr. Rabinowitz’s and Mr. Graham’s expertise will be critical as we look to improve further our products, ensure cohesive and effective regulation in the category, and raise awareness about e-cigarettes as a viable alternative for adult tobacco consumers not just in the US but globally.”
NJOY is known as the industry's Gold Standard for its product quality, patented technology, and responsible marketing. The company has a demonstrated commitment to advancing research and scientific understanding of electronic cigarettes and appointed Former Surgeon General Dr. Richard Carmona to its Board of Directors and Scientific Advisory Committee in March 2013.
About NJOY:
NJOY is known as the industry's "Gold Standard" due to its best-in-class products, patented technology, superior branding, experienced management team and responsible business practices. NJOY is the first independent electronic cigarette company to support the nationally recognized We Card Program and join its Manufacturers Advisory Council as part of its efforts to prevent underage use of its products. NJOY is currently in over 80,000 stores in the U.S. and more than 10,000 across the UK, France, Spain, Italy, Portugal and the Netherlands. NJOY offers disposable and rechargeable electronic cigarette products for adult smokers. These products provide nicotine with rich tobacco or menthol flavor, without tobacco smoke or odor. NJOY is headquartered in Scottsdale, Arizona and has offices in New York and London. To learn more about NJOY products visit www.NJOY.com.
Contacts
Sloane & Co.
Michelle Peters, 212-446-1889
mpeters@sloanepr.com
Permalink: http://me-newswire.net/news/9265/en
SCOTTSDALE, Ariz. - Friday, November 22nd 2013 [ME NewsWire]
(BUSINESS WIRE)-- NJOY, America’s number one independent electronic cigarette company, today announced the addition of two members to the Company’s senior leadership team, adding Dr. Joshua Rabinowitz as Chief Scientist and David Graham as Senior Vice President for International Regulatory Affairs. The addition of these highly-respected and experienced executives to oversee the company’s scientific research and international regulatory affairs reflects the commitment of NJOY to leadership in obsoleting tobacco cigarette smoking worldwide.
Dr. Joshua Rabinowitz, currently serving as a consultant, will join NJOY full time effective February 1, 2014. Dr. Rabinowitz is responsible for all science-related aspects of the business, including the laboratory and clinical testing of NJOY products, and oversight of product manufacturing and quality control. He will work closely with former U.S. Surgeon General Dr. Richard Carmona, the head of NJOY’s Scientific Advisory Committee.
Dr. Rabinowitz comes to NJOY on a leave of absence from Princeton University, where he is a full professor in the Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics. Dr. Rabinowitz received both an M.D. and Ph.D. from Stanford University. Thereafter, he co-founded Alexza Pharmaceuticals, where he invented the Adasuve Inhaler for treatment of acute agitation, an FDA-approved inhalation drug product. Dr. Rabinowitz is an inventor of more than 130 U.S. Patents and author of over 110 major journal articles, including seven in the past four years in Science or Nature.
David Graham, in a newly created position, will oversee all regulatory affairs in the U.S. and abroad. Mr. Graham was previously Senior Director of International Government Affairs at Johnson & Johnson, where he led tobacco control-related public policy for key markets around the globe. Before joining Johnson & Johnson, he was Senior Director of Global Public Policy for Pfizer, where he led public policy for their Tobacco Dependence business. Mr. Graham is a graduate of Columbia University School of International & Public Affairs with a Masters in Public Policy & Administration. He has more than 20 years of experience with tobacco control, smoking cessation, and related regulatory reforms.
“NJOY is committed to the scientific understanding of our products and advancing research of the e-cigarette industry. Recruiting individuals of this caliber is a testament to our early success, our Gold Standard practices and above all our full commitment to our mission—to obsolete cigarettes,” said Craig Weiss, Chief Executive Officer of NJOY. “Dr. Rabinowitz’s and Mr. Graham’s expertise will be critical as we look to improve further our products, ensure cohesive and effective regulation in the category, and raise awareness about e-cigarettes as a viable alternative for adult tobacco consumers not just in the US but globally.”
NJOY is known as the industry's Gold Standard for its product quality, patented technology, and responsible marketing. The company has a demonstrated commitment to advancing research and scientific understanding of electronic cigarettes and appointed Former Surgeon General Dr. Richard Carmona to its Board of Directors and Scientific Advisory Committee in March 2013.
About NJOY:
NJOY is known as the industry's "Gold Standard" due to its best-in-class products, patented technology, superior branding, experienced management team and responsible business practices. NJOY is the first independent electronic cigarette company to support the nationally recognized We Card Program and join its Manufacturers Advisory Council as part of its efforts to prevent underage use of its products. NJOY is currently in over 80,000 stores in the U.S. and more than 10,000 across the UK, France, Spain, Italy, Portugal and the Netherlands. NJOY offers disposable and rechargeable electronic cigarette products for adult smokers. These products provide nicotine with rich tobacco or menthol flavor, without tobacco smoke or odor. NJOY is headquartered in Scottsdale, Arizona and has offices in New York and London. To learn more about NJOY products visit www.NJOY.com.
Contacts
Sloane & Co.
Michelle Peters, 212-446-1889
mpeters@sloanepr.com
Permalink: http://me-newswire.net/news/9265/en
No comments:
Post a Comment